A randomized, double-blind, placebo-controlled study of sildenafil (Viagra) in Parkinson's disease men with erectile dysfunction
Phase of Trial: Phase II
Latest Information Update: 16 Apr 2011
At a glance
- Drugs Sildenafil (Primary)
- Indications Erectile dysfunction; Parkinson's disease
- Focus Therapeutic Use
- 16 Apr 2011 Status changed from not stated to completed.
- 16 Apr 2011 Results presented at the 63rd Annual Meeting of the American Academy of Neurology.
- 23 Aug 2006 Status change